Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...
Federal officials have a plan that could curb billions of dollars in overpayments to Medicare Advantage plans. But will they ...
A ceiling “maximum fair price” established by the Inflation Reduction Act will end up being an important driver of ...
This action comes in response to "years of warnings," according to The Centers for Medicare & Medicaid Services.
The Centers for Medicare & Medicaid Services Jan. 29 issued a final rule regarding states non-uniform or non-broad-based ...
The Centers for Medicare & Medicaid Services Jan. 26 released proposed changes to Medicare Advantage plan capitation rates and Part D payment policies for calendar year 2027, which the agency ...
The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...
The Centers for Medicare & Medicaid Services (CMS) finalized a rule Thursday afternoon clamping down on states’ Medicaid provider taxes. | Restrictions on "a Medicaid financing gimmick” through which ...
HealthDay News — Fifteen prescription medications, including Botox and the diabetes drug Trulicity, will be the focus of ...
Politicians make the program a scapegoat for runaway entitlements.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results